Houston, TX · Founded 2023 · Privately Held (backing)
Developer of a biotechnology data aggregation and analysis platform intended for analyzing biopharmaceutical developments. Biostate AI is based in Houston, TX and was founded in 2023. It was valued at $65 million at its early-stage round in May 2025, the last priced event on record. It has raised $16.7 million across 1 recorded round; the latest was a $4.2 million seed round in Apr 2025.
PMV mark · valuation
$65.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$16.7M
Last round
Seed Round
Apr 2025
No prints on record
No secondary trades in Biostate AI shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biostate AI with a free account
·The complete investor list: 23 names
·Watch Biostate AI: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Biostate AI stock.
